Gastrointestinal Testing Panels Market Overview:
As per MRFR analysis, the Gastrointestinal Testing Panels Market Size was estimated at 8.62 (USD Billion) in 2022. The Gastrointestinal Testing Panels Market is expected to grow from 9.2 (USD Billion) in 2023 to 16.57 (USD Billion) by 2032. The Gastrointestinal Testing Panels Market CAGR (growth rate) is expected to be around 6.76% during the forecast period (2024 - 2032).
Key Gastrointestinal Testing Panels Market Trends Highlighted
The Gastrointestinal Testing Panels Market is driven by the rising incidence of gastrointestinal diseases, the growing adoption of precision medicine, and increasing awareness about genetic testing.
Recent technological advancements in DNA sequencing and the development of non-invasive sampling methods are further expanding the market's growth potential.
Advances in molecular diagnostics are enabling the development of more comprehensive and accurate panels that can detect a wider range of gastrointestinal conditions, including genetic predispositions.
The expanding field of personalized medicine is creating opportunities for companies to develop targeted therapies based on genetic insights.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gastrointestinal Testing Panels Market Drivers
Increasing Prevalence of Gastrointestinal Disorders
Gastrointestinal (GI) disorders are a major global health concern, affecting millions of people worldwide. The rising incidence of conditions such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and colorectal cancer is a key driver of the growth in demand for gastrointestinal testing panels.
These panels provide valuable insights into the diagnosis and management of GI disorders, enabling healthcare professionals to make informed decisions about patient care.
The increasing prevalence of GI disorders is expected to continue driving the demand for gastrointestinal testing panels in the coming years.
Technological Advancements in Gastrointestinal Testing
Technological advancements are transforming the landscape of gastrointestinal testing. Non-invasive and minimally invasive technologies, such as capsule endoscopy and genetic testing, are becoming more common, making it easier for patients to undergo testing for GI problems.
Moreover, technological innovations have increased the utilization of gastrointestinal testing panels since they provide a more accurate and complete assessment of the GI system.
In addition, the development of various technologies is expected to help the Gastrointestinal Testing Panels Market grow in the future.
Growing Awareness of Gut Health
The public has become more aware of the significance of gut health. People understand that the balance of bacteria that inhabit their intestines determines many other vital functions of organisms. Awareness of this fact has resulted in an increased demand for the use of gut testing kits.
Gastrointestinal testing panels are needed to diagnose and treat certain diseases that imply gut problems. The reasons underlying such a requirement are related to preventive healthcare, which is currently in high demand. People opt for testing to ensure that they have no issues to be treated.
Gastrointestinal Testing Panels Market Segment Insights:
Gastrointestinal Testing Panels Market Test Type Insights
The Gastrointestinal Testing Panels Market is segmented by Test Type into Fecal Occult Blood Test (FOBT), Fecal Immunochemical Test (FIT), Stool DNA Test, Colonoscopy, and Upper Endoscopy.
Among these, FOBT is the most widely used test for colorectal cancer screening, and it is estimated to account for over 50% of the market share in 2024. FOBT is a simple and cost-effective test that can be performed at home, and it is recommended for individuals over the age of 50.
FIT is another popular test for colorectal cancer screening, and it is estimated to account for around 25% of the market share in 2024.
FIT is more sensitive than FOBT, but it is also more expensive. Stool DNA Test is a newer test for colorectal cancer screening, and it is estimated to account for around 15% of the market share in 2024. Stool DNA Test is the most sensitive test for colorectal cancer screening, but it is also the most expensive.
A colonoscopy is a procedure that allows doctors to visualize the inside of the colon and rectum. Colonoscopy is used to diagnose and treat a variety of gastrointestinal conditions, including colorectal cancer.
Upper Endoscopy is a procedure that allows doctors to visualize the inside of the esophagus, stomach, and duodenum.
Upper Endoscopy is used to diagnose and treat a variety of gastrointestinal conditions, including gastroesophageal reflux disease (GERD) and ulcers.
The growth of the market is attributed to the increasing prevalence of gastrointestinal diseases, the rising demand for early diagnosis and treatment, and the technological advancements in gastrointestinal testing panels.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gastrointestinal Testing Panels Market Biomarker Insights
The Biomarker segment is expected to witness significant growth in the Gastrointestinal Testing Panels Market, driven by the increasing prevalence of gastrointestinal diseases and the rising demand for personalized medicine.
Hemoglobin, Hemoglobin A1C, C-reactive Protein, CA 125, and CA 19-9 are key biomarkers used in gastrointestinal testing panels. Hemoglobin is a protein that carries oxygen in the blood, and its levels can indicate anemia or other blood disorders.
Hemoglobin A1C is a measure of long-term blood sugar control and is used to diagnose and monitor diabetes.
C-reactive Protein is a marker of inflammation, and elevated levels can indicate infection or other inflammatory conditions. CA 125 is a tumor marker used to screen for ovarian cancer, and CA 19-9 is a tumor marker used to screen for pancreatic cancer.
Gastrointestinal Testing Panels Market Patient Population Insights
The Gastrointestinal Testing Panels Market segmentation by Patient Population includes Cancer Patients, Chronic Disease Patients, Pregnant Women, Children, and Older Adults.
The Cancer Patients segment held the largest market share in 2023, owing to the rising incidence of gastrointestinal cancers and the need for early detection and monitoring.
The Chronic Disease Patients segment is also expected to witness significant growth due to the increasing prevalence of gastrointestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Pregnant Women segment is expected to grow steadily, driven by the increasing awareness of the importance of prenatal testing for gastrointestinal disorders.
Children and Older Adults segments are also expected to contribute to the market growth due to the increasing demand for early detection and monitoring of gastrointestinal disorders in these populations.
Gastrointestinal Testing Panels Market Sample Type Insights
Sample Type segment of the Gastrointestinal Testing Panels Market is highly diversified, with different sample types being used for various gastrointestinal tests. Blood samples are commonly utilized for a wide range of tests, including blood count, chemistry panels, and serological tests to detect antibodies or antigens.
Stool samples are essential for diagnosing infections, detecting parasites, and evaluating digestive function. Urine samples are employed for urinalysis to assess kidney function, detect infections, and screen for metabolic disorders.
Tissue biopsies are crucial for diagnosing gastrointestinal diseases, such as inflammatory bowel disease and celiac disease. Saliva samples are increasingly being used for non-invasive testing for gastrointestinal disorders, including Helicobacter pylori infection and oral cancer screening.
The Gastrointestinal Testing Panels Market revenue for Blood sample types is projected to reach USD 4.2 billion by 2024, while Stool sample types are estimated to account for USD 2.1 billion. The Urine sample types segment is expected to grow at a CAGR of 5.5%, reaching USD 1.5 billion by 2024.
Tissue and Saliva sample types are anticipated to contribute significantly to market growth, with emerging applications in precision medicine and personalized diagnostics.
Gastrointestinal Testing Panels Market Regional Insights
The Gastrointestinal Testing Panels Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period.
The growth of the North American market can be attributed to the increasing prevalence of gastrointestinal diseases, the rising adoption of advanced diagnostic technologies, and the presence of a well-established healthcare infrastructure.
Europe is the second-largest market for gastrointestinal testing panels and is expected to grow at a steady pace in the coming years.
The growth of the European market can be attributed to the increasing awareness of gastrointestinal diseases, the rising demand for personalized medicine, and the presence of a number of leading pharmaceutical and biotechnology companies.
The APAC market is expected to grow at the highest CAGR during the forecast period. The growth of the APAC market can be attributed to the increasing disposable income, the rising prevalence of gastrointestinal diseases, and the growing adoption of advanced diagnostic technologies. South America and MEA are expected to grow at a moderate pace during the forecast period.
The growth of these markets can be attributed to the increasing awareness of gastrointestinal diseases, the rising demand for personalized medicine, and the presence of a number of leading pharmaceutical and biotechnology companies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Gastrointestinal Testing Panels Market Key Players and Competitive Insights:
Major players in the Gastrointestinal Testing Panels Market are strategically focusing on product development to offer technologically advanced solutions for improved patient care.
They are investing in clinical research and developing innovative diagnostic tests to cater to the evolving needs of healthcare providers and patients.
Leading Gastrointestinal Testing Panels Market players are also expanding their geographical reach through partnerships and collaborations with local distributors and laboratories to increase their market presence.
Additionally, mergers and acquisitions are a key strategy adopted by Gastrointestinal Testing Panels Market participants to enhance their portfolio and strengthen their position in the competitive landscape.
A major player in the Gastrointestinal Testing Panels Market, Exact Sciences Corporation, focuses on developing non-invasive screening and diagnostic tests for gastrointestinal cancers, including colorectal cancer and esophageal cancer.
The company's flagship product, Cologuard, is a non-invasive stool-based DNA screening test for colorectal cancer. Exact Sciences Corporation has a robust pipeline of products in development, including a blood-based screening test for colorectal cancer and a molecular diagnostic test for esophageal cancer.
The company is also expanding its international presence and has partnerships with several leading healthcare providers worldwide.
In comparison, Enteromedics, a prominent competitor in the Gastrointestinal Testing Panels Market, offers a range of diagnostic tests for gastrointestinal disorders, including celiac disease, inflammatory bowel disease, and irritable bowel syndrome.
The company's tests are based on the analysis of specific biomarkers and genetic markers associated with these conditions. Enteromedics is focused on developing minimally invasive and accurate tests to enhance the diagnosis and management of gastrointestinal disorders.
The company has a strong presence in Europe and is expanding its operations in North America and the Asia-Pacific region through partnerships and collaborations.
Key Companies in the Gastrointestinal Testing Panels Market Include:
-
Olympus Corporation
-
BD (Becton, Dickinson and Company)
-
BioRad Laboratories
-
Becton, Dickinson and Company
-
F. HoffmannLa Roche Ltd
-
Mesa Laboratories
-
Thermo Fisher Scientific
-
Luminex Corporation
-
QIAGEN
-
Danaher Corporation
-
Siemens Healthineers
-
Sysmex Corporation
-
Merck KGaA
-
Abbott Laboratories
-
Biomérieux SA
Gastrointestinal Testing Panels Market Developments
The increasing prevalence of gastrointestinal diseases, technological advancements, and rising healthcare expenditure are driving the market growth.
Key recent developments include the launch of novel biomarker panels for early disease detection and the integration of artificial intelligence in data analysis for improved diagnostic accuracy.
The market is expected to witness significant growth in emerging economies due to increasing access to healthcare and rising disposable incomes.
Gastrointestinal Testing Panels Market Segmentation Insights
Gastrointestinal Testing Panels Market Test Type Outlook
- Fecal Occult Blood Test (FOBT)
- Fecal Immunochemical Test (FIT)
- Stool DNA Test
- Colonoscopy
- Upper Endoscopy
Gastrointestinal Testing Panels Market Biomarker Outlook
- Hemoglobin
- Hemoglobin A1C
- C-reactive Protein
- CA 125
- CA 19-9
Gastrointestinal Testing Panels Market Patient Population Outlook
- Cancer Patients
- Chronic Disease Patients
- Pregnant Women
- Children
- Older Adults
Gastrointestinal Testing Panels Market Sample Type Outlook
- Blood
- Stool
- Urine
- Tissue
- Saliva
Gastrointestinal Testing Panels Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
8.62(USD Billion) |
| Market Size 2023 |
9.2(USD Billion) |
| Market Size 2032 |
16.57(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
6.76% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Olympus Corporation, BD (Becton, Dickinson and Company), BioRad Laboratories, Becton, Dickinson and Company, F. HoffmannLa Roche Ltd, Mesa Laboratories, Thermo Fisher Scientific, Luminex Corporation, QIAGEN, Danaher Corporation, Siemens Healthineers, Sysmex Corporation, Merck KGaA, Abbott Laboratories, Biomérieux SA |
| Segments Covered |
Test Type, Biomarker, Patient Population, Sample Type, Regional |
| Key Market Opportunities |
Increasing prevalence of gastrointestinal diseases, technological advancements, growing awareness of genetic testing, expanding applications in personalized medicine, rising demand for noninvasive diagnostic tools |
| Key Market Dynamics |
Growing population Technological advancements Increase in healthcare expenditure Rising prevalence of gastrointestinal diseases Demand for personalized medicine |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Gastrointestinal Testing Panels Market size is expected to reach USD 16.57 Billion by 2032, exhibiting a CAGR of 6.76% during the forecast period (2024-2032).
North America is expected to dominate the Gastrointestinal Testing Panels Market, capturing a significant market share during the forecast period.
Rising prevalence of gastrointestinal diseases, technological advancements, and increasing healthcare expenditure are key factors driving the growth of the Gastrointestinal Testing Panels Market.
Major applications of Gastrointestinal Testing Panels include the diagnosis and monitoring of gastrointestinal diseases, such as inflammatory bowel disease, colorectal cancer, and celiac disease.
Key competitors in the Gastrointestinal Testing Panels Market include Abbott, Bio-Rad Laboratories, Danaher Corporation, and F. Hoffmann-La Roche.
The Gastrointestinal Testing Panels Market is expected to exhibit a CAGR of 6.76% during the forecast period (2024-2032).
Challenges faced by the Gastrointestinal Testing Panels Market include reimbursement issues, regulatory hurdles, and competition from alternative diagnostic methods.
Opportunities for growth in the Gastrointestinal Testing Panels Market include technological advancements, expanding healthcare infrastructure, and increasing awareness of gastrointestinal diseases.
The COVID-19 pandemic had a significant impact on the Gastrointestinal Testing Panels Market, leading to disruptions in healthcare systems and a decline in elective procedures.
The long-term prospects for the Gastrointestinal Testing Panels Market are positive, driven by rising healthcare expenditure, increasing awareness of gastrointestinal diseases, and technological advancements.
